ACADIA Pharmaceuticals Inc
F:DR6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
ACADIA Pharmaceuticals Inc
F:DR6
|
US |
|
F
|
Floor & Decor Holdings Inc
F:1FD
|
US |
|
F
|
Fifth Third Bancorp
XMUN:FFH
|
US |
Intrinsic Value
The intrinsic value of 
ACADIA Pharmaceuticals Inc (DR6) under the Base Case is 21.7 EUR per share.
Compared with the current market price of 17.54 EUR, the stock appears
Undervalued by 19% .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What ACADIA Pharmaceuticals Does
ACADIA Pharmaceuticals is a biopharmaceutical company that develops and sells prescription medicines for brain and nervous system disorders. Its main products are used by specialists and caregivers treating conditions that are hard to address with older drugs, especially diseases with limited treatment options.
- Headquarters
- United States of America US
- Employees
- 797
- IPO date
- May 27, 2004
Revenue & Expenses Breakdown
ACADIA Pharmaceuticals Inc
Earnings Waterfall
ACADIA Pharmaceuticals Inc
The intrinsic value for ACADIA Pharmaceuticals Inc (DR6) under the Base Case is 21.7 EUR.
Compared with the current market price of 17.54 EUR, the stock appears Undervalued by 19% .